BG
RPRX icon

BDF Gestion’s Royalty Pharma RPRX Stock Holding History

BDF Gestion’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Sell
21,258
-2,391
-10% -$124K 0.25% 104
2026
Q1 		$1.13M Hold
23,649
– – 0.15% 135
2025
Q4 		$914K Sell
23,649
-1,576
-6% -$60.1K 0.11% 141
2025
Q3 		$890K Sell
25,225
-5,246
-17% -$190K 0.11% 139
2025
Q2 		$1.1M Sell
30,471
-3,321
-10% -$110K 0.12% 132
2025
Q1 		$1.05M Hold
33,792
– – 0.11% 136
2024
Q4 		$862K Sell
33,792
-4,389
-11% -$116K 0.09% 134
2024
Q3 		$10M Hold
38,181
– – 1.08% 16
2024
Q2 		$1.01M Buy
+38,181
New +$1.06M 0.1% 148

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BDF Gestion's RPRX Position: Q2 2026 in Review

BDF Gestion reduced its Royalty Pharma (RPRX) stake by 10% in Q2 2026, selling an estimated $124K and leaving 21,258 shares worth $1.88M. The position accounts for 0.25% of the portfolio, ranked #104.

BDF Gestion first reported a position in RPRX in Q2 2024 and has held it in 9 quarters since. The position peaked at $10M in Q3 2024. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • BDF Gestion held 21,258 shares of Royalty Pharma worth $1.88M as of Q2 2026.
  • BDF Gestion sold 2,391 Royalty Pharma shares in Q2 2026, an estimated $124K.
  • Royalty Pharma made up 0.25% of BDF Gestion's portfolio in Q2 2026, its #104 holding.
  • BDF Gestion first reported a position in Royalty Pharma in Q2 2024 and has held it in 9 quarters since.
  • BDF Gestion's Royalty Pharma position peaked at $10M in Q3 2024.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on BDF Gestion's 13F filing for Q2 2026, filed 7 Jul 2026.